Autolus Therapeutics presents key data on Obecabtagene Autoleucel (obe-cel) at 2024 ASH Annual Meeting
Autolus Therapeutics announces the online publication of four abstracts submitted to the American Society of Hematology (ASH) Annual Meeting, to be held from December 7-10, 2024, in San… read more.
